New RSV Shot Shows Promise for Infant Protection

A novel single-dose shot for Respiratory Syncytial Virus (RSV) is demonstrating potential in safeguarding infants susceptible to severe forms of the illness. This emerging treatment could offer protection comparable to existing options while simplifying the administration process. Such a development is significant given that viral lung infections are a leading cause of infant hospitalizations.